ATH 25.0% 0.5¢ alterity therapeutics limited

I've been here a long while, held from the bottom to the top and...

  1. 3,401 Posts.
    lightbulb Created with Sketch. 72
    I've been here a long while, held from the bottom to the top and back again. Rudis letter leads to the idea of Pbt2 as a pointed prophylactic used well before symptoms in at risk populations which used to be a theme here amongst discussion. The way our human trials have been structured though couldn't be any different, all with patients in early onsetted disease . How do you sell five or ten year longitudinal studies of non sufferers to the market of however? I look back to the video of Mr Lawler who was quite a young sufferer and note his (possibly placebo, possibly not) improvement. Are younger sufferers displaying symptoms with a variant of the disease relying on less beta amyloid and therefore more sensitive to shifts in b-a concentrations? Regardless, bit worrisome when af and for that matter rt start up their engines again, rt has gone the formal letter route with his letter, hopefully that continues. I was never a fan of his tweeting.
    Last edited by dontaskme: 17/11/15
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
0.001(25.0%)
Mkt cap ! $26.19M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $27.94K 6.050M

Buyers (Bids)

No. Vol. Price($)
47 58163299 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 57489001 48
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
Last
0.5¢
  Change
0.001 ( 0.00 %)
Open High Low Volume
0.5¢ 0.5¢ 0.5¢ 20524121
Last updated 15.46pm 28/03/2024 ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.